The facility will help accommodate the 175 new high-wage jobs the company is creating and further enhance the strong economic profile of the city.
“Medtronic’s decision to expand its headquarters in Jacksonville demonstrates our commitment to R&D as a driver for economic and job growth,” said Governor Rick Scott. “Even more, this expansion reflects the success of our economic development partners working together to make Florida the best place for businesses to grow and create jobs.”
Once complete in 2015, the new building will add research and development, laboratory, marketing and customer training labs to the company’s headquarters.
“We are excited to grow our operations in Jacksonville,” said Mark Fletcher, senior vice president of Medtronic and president of Medtronic’s Surgical Technologies Division. “A well-trained workforce, the proximity to major universities, the business climate, an exceptional quality of life, and local and state support were all key factors that made Jacksonville by far the most attractive location for our expansion.”
Medtronic is the global leader in medical technology. It develops and manufactures a wide range of products and therapies to diagnose, prevent and monitor chronic conditions. Each year, the company’s therapies help more than seven million people worldwide.
The company’s new training facilities will increase its ability to effectively train medical professionals from around the world who visit the facilities for product training.
“Medtronic’s expansion will have a tremendous impact on our community by creating good-paying jobs that will broaden career options in Jacksonville’s workforce,” said Mayor Alvin Brown. “We are fortunate to have companies like Medtronic adding to an already-robust life sciences industry, which means so much to our economy and quality of life. This capital investment shows confidence in Jacksonville’s ability to draw innovation, new ideas and visitors from around the world.”
“The life sciences industry is expected to create an economic impact of $23.6 billion in our region annually and is one of our seven targeted industries,” said Robert Hill, chair of JAXUSA Partnership who is also president and CEO of Acosta Inc. “We applaud Medtronic’s investment in our community and expect it will assist with attracting further growth and development.”
Medtronic Surgical Technologies is Medtronic’s fastest growing division with revenues exceeding $1 billion per year and manufactures technologies for the treatment of ear, nose and throat diseases and cranial, spinal and neurologic conditions. The Division has operations in twelve locations worldwide, including the headquarters in Jacksonville.